Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
about
Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugatesA smart membrane based on an antigen-responsive hydrogel.HPMA copolymers: origins, early developments, present, and future.Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.Protein- and peptide-modified synthetic polymeric biomaterialsBiological rationale for the design of polymeric anti-cancer nanomedicines.Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.Biologically templated organic polymers with nanoscale order.Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapyCombination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cellsBiorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells.Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.Photosensitiser-antibody conjugates for photodynamic therapy.Modulating antibody pharmacokinetics using hydrophilic polymers.Polymers fight HIV: potent (pro)drugs identified through parallel automated synthesis.Biocatalytic polymer thin films: optimization of the multilayered architecture towards in situ synthesis of anti-proliferative drugs.Site-specific fab fragment biotinylation at the conserved nucleotide binding site for enhanced Ebola detection.Sunflower-shaped cyclodextrin-conjugated poly(epsilon-lysine) polyplex as a controlled intracellular trafficking device.Preparation of Fab' from murine IgG2a for thiol reactive conjugation.Design of smart HPMA copolymer-based nanomedicines.Polymer Cancerostatics Targeted with an Antibody Fragment Bound via a Coiled Coil Motif: In Vivo Therapeutic Efficacy against Murine BCL1 Leukemia.Enzyme Prodrug Therapy Engineered into BiomaterialsMacromolecular (pro)drugs in antiviral research
P2860
Q33263225-FB542415-79A0-4FD4-AF47-E0345C31DE2CQ33265600-94129A9E-A4CB-48F5-9AD0-CE34561F916BQ33719148-83F75EAA-96B8-407C-BAD2-69FCD856D184Q33943901-39D49877-AACE-4651-AFD4-80D6B03863EAQ35624524-BAC036EB-9437-4341-B508-2D731A3944F0Q36160333-DFC354A7-50AF-4D0D-9256-2267587DE66EQ36160805-1CD2AF1D-690B-41DB-8A0D-F05860FC17DFQ36446291-9060B847-0DD2-4FD6-B18C-C17F76EF1389Q36721737-61CBA812-3C5A-4940-A1E5-99424D53DE99Q36982369-0208DABF-C0C2-4A82-B2CB-B405ED13B1C0Q37107517-953D6509-618F-481F-BC26-3947A29F6FB1Q37218120-B9BA13C9-C573-46AC-A64C-9B3E7E1F887FQ37537969-9E490437-B24C-4433-A24E-38011D70C63CQ37853421-592E712E-09F7-46E0-A358-17259B276F91Q37919888-889CF976-FBD6-4B44-87E5-E2AC40299AAAQ38996924-3E167DC6-8B30-4270-80BE-5916A068A892Q39017881-A3261CA5-4B5A-4F98-86E6-6A29CAC0D7D0Q40169570-3B08E071-0DA5-465A-9B5D-1022BBBD125DQ40362446-B97A2534-A155-4C42-91A2-49717FBF1A53Q40770232-376CA690-90F1-43B3-9DF9-1AE86B7563A1Q42553783-07B3E218-FC65-4E41-80BF-9A8140DBB090Q47786062-6C0B6691-AB25-465F-A067-EE3B7E5DB93DQ56769203-C0270419-E9B0-458C-AF62-1CFFE8E3FFAAQ57376798-4FDFEE6F-9CB4-420E-B8C9-CD82F0860ACE
P2860
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@ast
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@en
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@nl
type
label
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@ast
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@en
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@nl
prefLabel
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@ast
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@en
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@nl
P2093
P2860
P356
P1433
P1476
Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
@en
P2093
P2860
P2888
P304
P356
10.1038/15085
P577
1999-11-01T00:00:00Z